Prevalent clinical symptoms, comorbidities, and treatment outcomes among COVID-19 patients in Abuja, Nigeria
DOI:
https://doi.org/10.53713/nhsj.v5i3.510Keywords:
COVID-19, disease, co-morbidities, impacts, isolation centersAbstract
Comorbidities are medical conditions that coexist with the disease of interest but are unrelated in causality or aetiology to the primary diagnosis. Until recently, the influence of these coexisting medical conditions on the outcome of care for patients with specific disease conditions has often been ignored. This study aims to determine the prevalent clinical presentation, comorbidities, and treatment outcomes among COVID-19 patients in Abuja, Nigeria. The retrospective study design was employed to select 1056 COVID-19 patients from the three selected isolation centres in Abuja. Results indicate that the most prevalent clinical presentation was dry cough, 960 (91.2%), shortness of breath, 677 (64.3%), and fever, 615 (58.2%). Significant comorbidities in the overall population were Diabetes with Hypertension, with a frequency of 165 out of 547; Hypertension alone represented 123 out of 547, and diabetes alone 96 out of 547. Regarding the outcome of care, cumulatively, of the 1056 patients that participated in this study, 123 (11.6%) mortality was recorded while the cumulative survival rate was 933 (88.4%). Furthermore, the result indicates that mortality among patients with diabetes and hypertension was highest at 45 (4.3%), followed by patients with diabetes alone at 25 (2.4%). Within fatal cases, an estimated 98.1% had the presence of one or more comorbidities. There is a significant relationship (p-value ≤ 0.01) between the prognosis of COVID-19 patients with comorbidities and those without comorbidities. Therefore, awareness, education, and lifestyle modification are advocated for those at risk of COVID-19.
References
Adedoyin, R. A., Mohammed, J., Ojukwu, C. P., Okafor, U. a. C., Oti, I. K., Onuchukwu, C. L., . . . Gbiri, C. a. O. (2020). Management of Patients with COVID-19 Infection in Acute Settings: A Position Paper for Cardiopulmonary Physiotherapists by the Association of Clinical and Academic Physiotherapists of Nigeria. Open Journal of Therapy and Rehabilitation, 08(03), 72–82. https://doi.org/10.4236/ojtr.2020.83007
Adegboye, O. A., Adekunle, A. I., & Gayawan, E. (2020). Early transmission dynamics of novel coronavirus (COVID-19) in Nigeria. International Journal of Environmental Research and Public Health, 17(9), 3054. https://doi.org/10.3390/ijerph17093054
Adhikari, S. P., Meng, S., Wu, Y., Mao, Y., Ye, R., Wang, Q., . . . Zhou, H. (2020). Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious Diseases of Poverty, 9(1). https://doi.org/10.1186/s40249-020-00646-x
Aiyegbusi, O. L., Hughes, S. E., Turner, G., Rivera, S. C., McMullan, C., Chandan, J. S., . . . Calvert, M. J. (2021). Symptoms, complications, and management of long COVID: a review. Journal of the Royal Society of Medicine, 114(9), 428–442. https://doi.org/10.1177/01410768211032850
Akinbolagbe, Y. O., Otrofanowei, E., Akase, I. E., Akintan, P. E., Ima-Edomwonyi, U. E., Olopade, B. O., . . . Esezobor, C. (2021). Predictors and outcomes of COVID-19 patients with hypoxemia in Lagos, Nigeria. Journal of the Pan African Thoracic Society, 3, 42–50. https://doi.org/10.25259/jpats_25_2021
Alimohamadi, Y., Holakouie-Naieni, K., Sepandi, M., & Taghdir, M. (2020). Effect of Social Distancing on COVID-19 Incidence and Mortality in Iran Since February 20 to May 13, 2020: An Interrupted Time Series Analysis. Risk Management and Healthcare Policy, 13, 1695–1700. https://doi.org/10.2147/rmhp.s265079
Amzat, J., Aminu, K., Kolo, V. I., Akinyele, A. A., Ogundairo, J. A., & Danjibo, M. C. (2020). Coronavirus outbreak in Nigeria: Burden and socio-medical response during the first 100 days. International Journal of Infectious Diseases, 98, 218–224. https://doi.org/10.1016/j.ijid.2020.06.067
Anjorin, A., Abioye, A., Asowata, O., Soipe, A., Kazeem, M., Adesanya, I., . . . Omotayo, M. (2020). Comorbidities and the COVID‐19 pandemic dynamics in Africa. Tropical Medicine & International Health, 26(1), 2–13. https://doi.org/10.1111/tmi.13504
Balogun, J. A. (2022). The vulnerabilities of the Nigerian healthcare system. In The Nigerian healthcare system: pathway to universal and high-quality health care (pp. 117-152). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-030-88863-3_5
Baradaran, A., Ebrahimzadeh, M. H., Baradaran, A., & Kachooei, A. R. (2020). Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis. PubMed, 8(Suppl 1), 247–255. https://doi.org/10.22038/abjs.2020.47754.2346
Elezkurtaj, S., Greuel, S., Ihlow, J., Michaelis, E. G., Bischoff, P., Kunze, C. A., . . . Horst, D. (2021). Causes of death and comorbidities in hospitalized patients with COVID-19. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-82862-5
Esakandari, H., Nabi-Afjadi, M., Fakkari-Afjadi, J., Farahmandian, N., Miresmaeili, S., & Bahreini, E. (2020). A comprehensive review of COVID-19 characteristics. Biological Procedures Online, 22(1). https://doi.org/10.1186/s12575-020-00128-2
Khedr, E. M., Daef, E., Mohamed-Hussein, A., Mostafa, E. F., Zein, M., Hassany, S. M., . . . Hashem, M. K. (2020). Impact of comorbidities on COVID-19 outcome. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.11.28.20240267
Nishiura, H., Oshitani, H., Kobayashi, T., Saito, T., Sunagawa, T., Matsui, T., . . . Suzuki, M. (2020). Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19). medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.02.28.20029272
Osibogun, A., Balogun, M., Abayomi, A., Idris, J., Kuyinu, Y., Odukoya, O., . . . Akinroye, K. (2021). Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS ONE, 16(3), e0248281. https://doi.org/10.1371/journal.pone.0248281
Otuonye, N. M., Olumade, T. J., Ojetunde, M. M., Holdbrooke, S. A., Ayoola, J. B., Nyam, I. Y., . . . Odunukwe, N. N. (2020). Clinical and Demographic Characteristics of COVID-19 patients in Lagos, Nigeria: A Descriptive Study. Journal of the National Medical Association, 113(3), 301–306. https://doi.org/10.1016/j.jnma.2020.11.011
Owusu, A. B., Yiran, G. a. B., Afagbedzi, S. K., & Takyi, E. (2023). District-level analysis of sociodemographic factors and COVID-19 infections in Greater Accra and Ashanti regions, Ghana. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1140108
Patrascu, I., Lehene, M., & Bercea, I. (2023). Comorbidities of COVID-19 Patients. Medicina, 59(8), 1393. https://doi.org/10.3390/medicina59081393
Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O’Donnell, L., Chernyak, Y., . . . Horwitz, L. I. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ, m1966. https://doi.org/10.1136/bmj.m1966
Putri, P. (2024). The Relationship between Family Support and Patient Anxiety when Undergoing Rapid Screening Tests COVID-19 in Hospitals. Nursing and Health Sciences Journal (NHSJ), 4(3), 300–305. https://doi.org/10.53713/nhsj.v4i3.383
Reuben, R. C., Danladi, M. M. A., Saleh, D. A., & Ejembi, P. E. (2020). Knowledge, Attitudes and Practices towards COVID-19: An epidemiological survey in North-Central Nigeria. Journal of Community Health, 46(3), 457–470. https://doi.org/10.1007/s10900-020-00881-1
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., . . . Altaf, M. (2020). Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1069–1076. https://doi.org/10.1007/s42399-020-00363-4
Singh, A. K., Gupta, R., Ghosh, A., & Misra, A. (2020). Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes & Metabolic Syndrome Clinical Research & Reviews, 14(4), 303–310. https://doi.org/10.1016/j.dsx.2020.04.004
Singh, P., Bhaskar, Y., Verma, P., Rana, S., Goel, P., Kumar, S., . . . Singh, H. (2023). Impact of comorbidity on patients with COVID-19 in India: A nationwide analysis. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.1027312
Yasin, D. D. F., Akhiat, N., Lazuardi, S., Fraghini, C., & Wildan, M. (2024). The impact of Parenting styles based on the Health Belief Model on School-Age Children’s Personal Hygiene in the Bangka region. Nursing and Health Sciences Journal (NHSJ), 4(4), 408–414. https://doi.org/10.53713/nhsj.v4i4.422
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N., . . . Lin, S. (2020). The impact of COPD and smoking history on the severity of COVID‐19: A systematic review and meta‐analysis. Journal of Medical Virology, 92(10), 1915–1921. https://doi.org/10.1002/jmv.25889
